Træk
Anorexia
Lack of desire to eat (loss of appetite).
Resumé
- Også kaldet
- Deliberately not eating, Obsessive dieting, Refusing to eat
- Kropssystem
- Abnormality of the digestive system
ReferencegenomGRCh38hg38
Positioner på gen- og variantsider følger dette valg i denne browser.
Read the genes linked to Anorexia, and the rest of your genome, with one test.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger
Bestil min Genome Test132 gener knyttet til Anorexia
Ændringer i disse gener forårsager sjældne tilstande, hvor Anorexia ses. De fleste med dette træk har ingen af disse tilstande, og et gen på denne liste siger intet om nogens eget genom.
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| ITPR3inositol 1,4,5-trisphosphate receptor type 3 | Altid | I 1 tilstand |
| NFS1NFS1 cysteine desulfurase | Altid | I 1 tilstand |
| PTCRApre T cell antigen receptor alpha | Altid | I 1 tilstand |
| BANK1B cell scaffold protein with ankyrin repeats 1 | Meget ofte (80–99 %) | I 1 tilstand |
| BLKBLK proto-oncogene, Src family tyrosine kinase | Meget ofte (80–99 %) | I 1 tilstand |
| BRCA1BRCA1 DNA repair associated | Meget ofte (80–99 %) | I 2 tilstande |
| BRCA2BRCA2 DNA repair associated | Meget ofte (80–99 %) | I 2 tilstande |
| C4Acomplement C4A (Chido/Rodgers blood group) | Meget ofte (80–99 %) | I 2 tilstande |
| C4Bcomplement C4B (Chido/Rodgers blood group) | Meget ofte (80–99 %) | I 1 tilstand |
| CD4CD4 molecule | Meget ofte (80–99 %) | I 1 tilstand |
| CDKN2Acyclin dependent kinase inhibitor 2A | Meget ofte (80–99 %) | I 1 tilstand |
| CR2complement C3d receptor 2 | Meget ofte (80–99 %) | I 1 tilstand |
| CTLA4cytotoxic T-lymphocyte associated protein 4 | Meget ofte (80–99 %) | I 1 tilstand |
| DNASE1deoxyribonuclease 1 | Meget ofte (80–99 %) | I 1 tilstand |
| ETS1ETS proto-oncogene 1, transcription factor | Meget ofte (80–99 %) | I 1 tilstand |
| FCGR2BFc gamma receptor IIb | Meget ofte (80–99 %) | I 1 tilstand |
| FCGR3BFc gamma receptor IIIb | Meget ofte (80–99 %) | I 1 tilstand |
| GBA1glucosylceramidase beta 1 | Meget ofte (80–99 %) | I 1 tilstand |
| HLA-Bmajor histocompatibility complex, class I, B | Meget ofte (80–99 %) | I 3 tilstande |
| HLA-DRB1major histocompatibility complex, class II, DR beta 1 | Meget ofte (80–99 %) | I 3 tilstande |
| HLCSholocarboxylase synthetase | Meget ofte (80–99 %) | I 1 tilstand |
| IGHG1immunoglobulin heavy constant gamma 1 (G1m marker) | Meget ofte (80–99 %) | I 1 tilstand |
| IL10interleukin 10 | Meget ofte (80–99 %) | I 2 tilstande |
| IRAK1interleukin 1 receptor associated kinase 1 | Meget ofte (80–99 %) | I 1 tilstand |
| IRF4interferon regulatory factor 4 | Meget ofte (80–99 %) | I 1 tilstand |
| IRF5interferon regulatory factor 5 | Meget ofte (80–99 %) | I 1 tilstand |
| ITGAMintegrin subunit alpha M | Meget ofte (80–99 %) | I 1 tilstand |
| JAZF1JAZF zinc finger 1 | Meget ofte (80–99 %) | I 1 tilstand |
| KIAA0319LKIAA0319 like | Meget ofte (80–99 %) | I 1 tilstand |
| KRASKRas proto-oncogene, GTPase | Meget ofte (80–99 %) | I 1 tilstand |
| MECP2methyl-CpG binding protein 2 | Meget ofte (80–99 %) | I 2 tilstande |
| MMADHCmetabolism of cobalamin associated D | Meget ofte (80–99 %) | I 1 tilstand |
| MMUTmethylmalonyl-CoA mutase | Meget ofte (80–99 %) | I 1 tilstand |
| P4HA2prolyl 4-hydroxylase subunit alpha 2 | Meget ofte (80–99 %) | I 1 tilstand |
| PALB2partner and localizer of BRCA2 | Meget ofte (80–99 %) | I 1 tilstand |
| PALLDpalladin, cytoskeletal associated protein | Meget ofte (80–99 %) | I 1 tilstand |
| PDCD1programmed cell death 1 | Meget ofte (80–99 %) | I 1 tilstand |
| PTPN22protein tyrosine phosphatase non-receptor type 22 | Meget ofte (80–99 %) | I 2 tilstande |
| PXKPX domain containing serine/threonine kinase like | Meget ofte (80–99 %) | I 1 tilstand |
| RABL3RAB, member of RAS oncogene family like 3 | Meget ofte (80–99 %) | I 1 tilstand |
Vis 92 gener mere
| Gen | Hvor ofte det ses | Tilstande |
|---|---|---|
| SCARB2scavenger receptor class B member 2 | Meget ofte (80–99 %) | I 1 tilstand |
| SLC19A2solute carrier family 19 member 2 | Meget ofte (80–99 %) | I 1 tilstand |
| SLC46A1solute carrier family 46 member 1 | Meget ofte (80–99 %) | I 1 tilstand |
| SMAD4SMAD family member 4 | Meget ofte (80–99 %) | I 1 tilstand |
| SPP1secreted phosphoprotein 1 | Meget ofte (80–99 %) | I 1 tilstand |
| STAT4signal transducer and activator of transcription 4 | Meget ofte (80–99 %) | I 2 tilstande |
| TLR7toll like receptor 7 | Meget ofte (80–99 %) | I 1 tilstand |
| TNFAIP3TNF alpha induced protein 3 | Meget ofte (80–99 %) | I 1 tilstand |
| TNFSF4TNF superfamily member 4 | Meget ofte (80–99 %) | I 1 tilstand |
| TNIP1TNFAIP3 interacting protein 1 | Meget ofte (80–99 %) | I 1 tilstand |
| TP53tumor protein p53 | Meget ofte (80–99 %) | I 1 tilstand |
| TREX1three prime repair exonuclease 1 | Meget ofte (80–99 %) | I 1 tilstand |
| UBE2L3ubiquitin conjugating enzyme E2 L3 | Meget ofte (80–99 %) | I 1 tilstand |
| AQP2aquaporin 2 | Ofte (30–79 %) | I 1 tilstand |
| ASXL1ASXL transcriptional regulator 1 | Ofte (30–79 %) | I 1 tilstand |
| ATMATM serine/threonine kinase | Ofte (30–79 %) | I 1 tilstand |
| ATP1A2ATPase Na+/K+ transporting subunit alpha 2 | Ofte (30–79 %) | I 1 tilstand |
| ATP1A3ATPase Na+/K+ transporting subunit alpha 3 | Ofte (30–79 %) | I 1 tilstand |
| ATRXATRX chromatin remodeler | Ofte (30–79 %) | I 1 tilstand |
| AVPR2arginine vasopressin receptor 2 | Ofte (30–79 %) | I 1 tilstand |
| BCORBCL6 corepressor | Ofte (30–79 %) | I 1 tilstand |
| CACNA1Acalcium voltage-gated channel subunit alpha1 A | Ofte (30–79 %) | I 1 tilstand |
| CBLCbl proto-oncogene | Ofte (30–79 %) | I 1 tilstand |
| CCND1cyclin D1 | Ofte (30–79 %) | I 1 tilstand |
| FIP1L1factor interacting with PAPOLA and CPSF1 | Ofte (30–79 %) | I 1 tilstand |
| GLAgalactosidase alpha | Ofte (30–79 %) | I 1 tilstand |
| HMGCL3-hydroxy-3-methylglutaryl-CoA lyase | Ofte (30–79 %) | I 1 tilstand |
| IGHimmunoglobulin heavy locus | Ofte (30–79 %) | I 1 tilstand |
| IL12Binterleukin 12B | Ofte (30–79 %) | I 1 tilstand |
| IRF2BP2interferon regulatory factor 2 binding protein 2 | Ofte (30–79 %) | I 1 tilstand |
| MC2Rmelanocortin 2 receptor | Ofte (30–79 %) | I 1 tilstand |
| MLXMAX dimerization protein MLX | Ofte (30–79 %) | I 1 tilstand |
| MRAPmelanocortin 2 receptor accessory protein | Ofte (30–79 %) | I 1 tilstand |
| MT-TL2mitochondrially encoded tRNA-Leu (CUN) 2 | Ofte (30–79 %) | I 1 tilstand |
| NABP1nucleic acid binding protein 1 | Ofte (30–79 %) | I 1 tilstand |
| NAGSN-acetylglutamate synthase | Ofte (30–79 %) | I 1 tilstand |
| NNTnicotinamide nucleotide transhydrogenase | Ofte (30–79 %) | I 1 tilstand |
| NPM1nucleophosmin 1 | Ofte (30–79 %) | I 1 tilstand |
| NUMA1nuclear mitotic apparatus protein 1 | Ofte (30–79 %) | I 1 tilstand |
| OTCornithine transcarbamylase | Ofte (30–79 %) | I 1 tilstand |
| PMLPML nuclear body scaffold | Ofte (30–79 %) | I 1 tilstand |
| PRKAR1Aprotein kinase cAMP-dependent type I regulatory subunit alpha | Ofte (30–79 %) | I 1 tilstand |
| RARAretinoic acid receptor alpha | Ofte (30–79 %) | I 1 tilstand |
| RHOBTB2Rho related BTB domain containing 2 | Ofte (30–79 %) | I 1 tilstand |
| RUNX1RUNX family transcription factor 1 | Ofte (30–79 %) | I 1 tilstand |
| SCN2Asodium voltage-gated channel alpha subunit 2 | Ofte (30–79 %) | I 1 tilstand |
| SLC1A3solute carrier family 1 member 3 | Ofte (30–79 %) | I 1 tilstand |
| SLC2A1solute carrier family 2 member 1 | Ofte (30–79 %) | I 1 tilstand |
| SRSF2serine and arginine rich splicing factor 2 | Ofte (30–79 %) | I 1 tilstand |
| STARsteroidogenic acute regulatory protein | Ofte (30–79 %) | I 1 tilstand |
| STAT3signal transducer and activator of transcription 3 | Ofte (30–79 %) | I 1 tilstand |
| STAT5Bsignal transducer and activator of transcription 5B | Ofte (30–79 %) | I 1 tilstand |
| TBL1XR1TBL1X/Y related 1 | Ofte (30–79 %) | I 1 tilstand |
| TET2tet methylcytosine dioxygenase 2 | Ofte (30–79 %) | I 2 tilstande |
| TXNRD2thioredoxin reductase 2 | Ofte (30–79 %) | I 1 tilstand |
| ZBTB16zinc finger and BTB domain containing 16 | Ofte (30–79 %) | I 1 tilstand |
| ACAT1acetyl-CoA acetyltransferase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| CALRcalreticulin | Nogle gange (5–29 %) | I 1 tilstand |
| CBScystathionine beta-synthase | Nogle gange (5–29 %) | I 1 tilstand |
| CCR1C-C motif chemokine receptor 1 | Nogle gange (5–29 %) | I 1 tilstand |
| CD247CD247 molecule | Nogle gange (5–29 %) | I 1 tilstand |
| CD3DCD3 delta subunit of T-cell receptor complex | Nogle gange (5–29 %) | I 1 tilstand |
| CD3ECD3 epsilon subunit of T-cell receptor complex | Nogle gange (5–29 %) | I 1 tilstand |
| CDKN1Bcyclin dependent kinase inhibitor 1B | Nogle gange (5–29 %) | I 1 tilstand |
| CDKN2Bcyclin dependent kinase inhibitor 2B | Nogle gange (5–29 %) | I 1 tilstand |
| ERAP1endoplasmic reticulum aminopeptidase 1 | Nogle gange (5–29 %) | I 1 tilstand |
| FASFas cell surface death receptor | Nogle gange (5–29 %) | I 1 tilstand |
| FLI1Fli-1 proto-oncogene, ETS transcription factor | Nogle gange (5–29 %) | I 1 tilstand |
| IFNGR1interferon gamma receptor 1 | Nogle gange (5–29 %) | I 2 tilstande |
| IL12Ainterleukin 12A | Nogle gange (5–29 %) | I 1 tilstand |
| IL12A-AS1IL12A antisense RNA 1 | Nogle gange (5–29 %) | I 1 tilstand |
| IL23Rinterleukin 23 receptor | Nogle gange (5–29 %) | I 1 tilstand |
| JAK2Janus kinase 2 | Nogle gange (5–29 %) | I 1 tilstand |
| KLRC4killer cell lectin like receptor C4 | Nogle gange (5–29 %) | I 1 tilstand |
| MEFVMEFV innate immunity regulator, pyrin | Nogle gange (5–29 %) | I 1 tilstand |
| MEN1menin 1 | Nogle gange (5–29 %) | I 1 tilstand |
| MPLMPL proto-oncogene, thrombopoietin receptor | Nogle gange (5–29 %) | I 1 tilstand |
| MYD88MYD88 innate immune signal transduction adaptor | Nogle gange (5–29 %) | I 1 tilstand |
| PKHD1PKHD1 ciliary IPT domain containing fibrocystin/polyductin | Nogle gange (5–29 %) | I 1 tilstand |
| PTPN3protein tyrosine phosphatase non-receptor type 3 | Nogle gange (5–29 %) | I 1 tilstand |
| ROS1ROS proto-oncogene 1, receptor tyrosine kinase | Nogle gange (5–29 %) | I 1 tilstand |
| SDHAsuccinate dehydrogenase complex flavoprotein subunit A | Nogle gange (5–29 %) | I 1 tilstand |
| SDHBsuccinate dehydrogenase complex iron sulfur subunit B | Nogle gange (5–29 %) | I 1 tilstand |
| SDHCsuccinate dehydrogenase complex subunit C | Nogle gange (5–29 %) | I 1 tilstand |
| SLC39A4solute carrier family 39 member 4 | Nogle gange (5–29 %) | I 1 tilstand |
| SYKspleen associated tyrosine kinase | Nogle gange (5–29 %) | I 1 tilstand |
| TGFB1transforming growth factor beta 1 | Nogle gange (5–29 %) | I 1 tilstand |
| TLR4toll like receptor 4 | Nogle gange (5–29 %) | I 1 tilstand |
| UBAC2UBA domain containing 2 | Nogle gange (5–29 %) | I 1 tilstand |
| ALPLalkaline phosphatase, biomineralization associated | Ikke registreret | I 1 tilstand |
| ARG1arginase 1 | Ikke registreret | I 1 tilstand |
| SLC4A1solute carrier family 4 member 1 (Diego blood group) | Ikke registreret | I 1 tilstand |
Hvor hyppigt det ses hos personer med en af genets tilstande, den hyppigste værdi på tværs af dem, sådan som Human Phenotype Ontology registrerer det. Disse sider beskriver egenskaber og den forskning, der ligger bag dem. De er ikke en diagnose, og hvis du har spørgsmål om symptomer, bør du spørge en læge eller genetisk rådgiver.
Bredere træk
Hvor oplysningerne kommer fra
- Human Phenotype Ontology, udgivelse 2026-09-01: egenskaben, dens navne, definition og de gener, der er knyttet til den. Læs mere på hpo.jax.org.
- Dataudgivelse 2026.10.16-c6eea6bf.
Én test. Svar for hele livet.
Fra 449 $Gratis forsendelse · Resultater på 6–8 uger